Announcement on the Progress of Guarantees for Subsidiaries

Announcement on the Progress of Guarantees for Subsidiaries

The company and the board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement, and that there are no false representations, misleading statements, or material omissions.

Yingke Medical Technology Co., Ltd. (hereinafter referred to as the "Company") held its Fourth Board of Directors' Fourteenth Meeting (Regular) on April 23, 2026, and its 2025 Annual Shareholders' Meeting on May 18, 2026, both of which deliberated and approved the "Proposal on the Company and its Subsidiaries Applying for Credit Lines and Guarantees from Banks." To meet the production and operational needs of the Company and its subsidiaries, the Company and its subsidiaries plan to apply for a comprehensive credit line and financial derivative trading risk limit from banks and other financial institutions, with a total amount not exceeding RMB 29.95 billion. The total amount of guarantees shall not exceed RMB 29.95 billion, with an authorization period from the date of approval by the Company's 2025 Annual Shareholders' Meeting until the next annual shareholders' meeting. For detailed information, please refer to the "Announcement on the Company and its Subsidiaries Applying for Credit Lines and Guarantees from Banks" and the "Announcement on the Resolution of the 2025 Annual Shareholders' Meeting" (Announcement Numbers: 2026-023, 2026-036) published on thecninfo.com.cn.

I. Overview of Guarantee Matters

Anhui Yingke Medical Products Co., Ltd. (hereinafter referred to as "Anhui Yingke") requires operational needs and has applied for a credit line from China Everbright Bank Co., Ltd. Hefei Branch (hereinafter referred to as "Everbright Bank Hefei Branch"). The Company provides a joint liability guarantee for the aforementioned credit line amounting to RMB 200 million.

Anhui Yingke requires operational needs and has applied for a credit line from Industrial and Commercial Bank of China Limited Suixi Branch (hereinafter referred to as "ICBC Suixi Branch"). The Company and its wholly-owned subsidiary Jiangxi Yingke Medical Technology Co., Ltd. (hereinafter referred to as "Jiangxi Yingke") jointly provide a joint liability guarantee for the aforementioned credit line totaling RMB 50 million. They have recently signed "Guarantee Contracts" (hereinafter referred to as "Guarantee Contract Two" and "Guarantee Contract Three") with ICBC Suixi Branch respectively.

Anhui Kaize New Material Co., Ltd. (hereinafter referred to as "Anhui Kaize") requires operational needs and has applied for a credit line from Everbright Bank Hefei Branch. The Company provides a joint liability guarantee for the aforementioned credit line amounting to RMB 100 million and has recently signed a "Maximum Amount Guarantee Contract" (hereinafter referred to as "Guarantee Contract Four") with Everbright Bank Hefei Branch.

Jiangsu Yingke Medical Products Co., Ltd. (hereinafter referred to as "Jiangsu Yingke") requires operational needs and has applied for a credit line from China Merchants Bank Co., Ltd. Zhenjiang Branch (hereinafter referred to as "CMB Zhenjiang Branch"). The Company provides a joint liability guarantee for the aforementioned credit line amounting to RMB 30 million and has recently signed a "Maximum Amount Irrevocable Guarantee Letter" (hereinafter referred to as "Guarantee Contract Five") with CMB Zhenjiang Branch.

The progress of this guarantee is as follows: